Nuclear epidermal growth factor receptor interacts with transcriptional intermediary factor 2 to activate cyclin D1 gene expression triggered by the oncoprotein latent membrane protein 1

Carcinogenesis
Yin ShiYa Cao

Abstract

The epidermal growth factor receptor (EGFR), a ubiquitously expressed receptor tyrosine kinase, is an important factor in carcinogenesis. Transcriptional intermediary factor 2 (TIF2), a member of the p160 nuclear receptor co-activator gene family, is linked to the proliferation of cancer cells. However, the direct interplay between the EGFR and the nuclear receptors remains unclear. Our previous study demonstrated that nuclear EGFR could directly bind to the cyclin D1 promoter under the regulation of the oncoprotein latent membrane protein 1 (LMP1), but it also indicated that other factors are involved in the activation of target genes. In this study, we found that LMP1 upregulated the expression of TIF2 and promoted the interaction of EGFR with TIF2 in nasopharyngeal carcinoma. Furthermore, we demonstrated that the intact complex was linked with cyclin D1 promoter activity in an LMP1-dependent manner. The physiological functions of the intact complex were associated with cell proliferation and cell cycle progression. These findings suggest that TIF2 is a novel binding partner for nuclear EGFR and is involved in regulating its target gene expression.

References

May 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bettina Grasl-KrauppRolf Schulte-Hermann
May 9, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hirotaka Iwase
Jun 14, 2003·Molecular Endocrinology·Jianming Xu, Qingtian Li
Nov 20, 2003·Nature Reviews. Molecular Cell Biology·Mar Carmena, William C Earnshaw
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carlos L Arteaga
Dec 10, 2003·The Journal of Biological Chemistry·Christopher W GregoryElizabeth M Wilson
Oct 8, 2005·Advances in Anatomic Pathology·R S RampaulI O Ellis
Nov 22, 2005·Molecular Carcinogenesis·Norihisa HanadaMien-Chie Hung
Nov 7, 2006·Trends in Cell Biology·Bryan Linggi, Graham Carpenter
Nov 23, 2006·Nature Cell Biology·Shao-Chun WangMien-Chie Hung
Oct 5, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D C W LeeA S Y Lau
Nov 27, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Gabriele WannerKlaus Dittmann
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yurii ChinenovInez Rogatsky
Feb 10, 2009·International Journal of Colorectal Disease·Petros D GrivasHaralabos Kalofonos
Feb 11, 2010·Molecular Cancer Research : MCR·Hui-Wen LoFrancis Ali-Osman
Apr 9, 2010·BMC Cancer·Yuanzheng HeS Stoney Simons
Aug 31, 2010·Proceedings of the National Academy of Sciences of the United States of America·Longfei HuoMien-Chie Hung
Jun 28, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Klaus DittmannH Peter Rodemann

❮ Previous
Next ❯

Citations

Jul 3, 2013·The Lancet Oncology·Barbara BurtnessThomas Galloway
Jul 17, 2013·American Journal of Respiratory and Critical Care Medicine·Charles A PowellSerge P Nana-Sinkam
Feb 8, 2014·Oral Oncology·Randy Y C Poon
Feb 16, 2016·Cancer Cell International·Marco Allán Pérez-SolisArturo Aguilar-Rojas
Feb 26, 2016·Carcinogenesis·Jack Zhang, Andy Babic
Feb 7, 2014·Journal of Experimental & Clinical Cancer Research : CR·Yang XuYa Cao
Apr 22, 2017·Cellular Signalling·Hongsen LiWeidong Han
Oct 27, 2018·Biologie aujourd'hui·Sylvie Gazzeri
Sep 21, 2019·The Journal of Biological Chemistry·Marcelo Coutinho de MirandaDawidson A Gomes
Jun 30, 2019·Journal of Experimental & Clinical Cancer Research : CR·Rui YangYongguang Tao
Jun 18, 2020·Signal Transduction and Targeted Therapy·Lianlian OuyangYongguang Tao
Aug 29, 2020·The International Journal of Biochemistry & Cell Biology·Sara Teixeira Soares MotaThaise Gonçalves Araújo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.